frame-mounted valve made of autologous fascia lata removed from the thigh.
Subjects and methods.
Between June 1969 and August 1970, 8o patients had isolated aortic valve replacement with frame-mounted autologous fascia lata at the National Heart Hospital, London. These represent all patients seen at the hospital during this period who required lone aortic valve replacement, except for a few emergency operations where prosthetic valves were used to enable the operation to be made as quickly as possible and 8 where unsupported fascial valves were used. However, the latter were found to be unsatisfactory and were soon abandoned in favour of supported fascial valves. Patients were aged 22 to 63 with an average age of 47-2 years. Sixty-four were male and i6 were female. Twenty-seven had congenital aortic valve disease, and 42 had rheumatic disease; there were single examples of Marfan's syndrome and syphilitic aortic valve disease and in 9 patients the aetiology was uncertain, but probably congenital. Thirty-five patients had dominant aortic stenosis, 32 had dominant regurgitation, and 9 had a mixed lesion. In 4 patients the indication for operation was haemolysis from a regurgitant Starr-Edwards prosthesis. Twelve patients had had previous aortic valve replacement and one an open aortic valvotomy. Ten patients had additional mitral valve disease, one of whom also had tricuspid disease.
Thirty-six patients had been in recent left ventricular Aortic valve replacement with frame-mounted autologous fascia lata 76I failure and one had active infective endocarditis with low cardiac output state. All had important left ventricular hypertrophy. Three patients had had recently treated infective endocarditis. Four patients had additional clinical coronary artery disease.
Methods After a strip of fascia lata was removed from the lateral aspect of the thigh, the valve was prepared on a frame as previously described (Ionescu and Ross, I969; Ionescu et al., I97oa, b) . Normothermic cardiopulmonary bypass was used in all patients and the length of bypass varied from 48 to I39 minutes; intermittent coronary perfusion was used and the total period of ischaemic arrest was between 7 and 8o minutes. The diameter of the frame was 20 mm in 22 (Table i) . The first was a patient operated on during active infection who died 2 months later after a second operation for persistence of aortic regurgitation and a ventricular septal defect. Aortic regurgitation was peripheral due to a dehiscence of sutures, and the cusps looked healthy. Three patients died from the effects of active infective endocarditis, 2 at 5 months and I at 34 months. One patient with mild aortic regurgitation died at 7 months after additional mitral valve surgery and another with mild aortic regurgitation died after operation for secondary subvalve obstruction. The seventh patient died at operation for aortic regurgitation at 40 months, and an eighth patient died suddenly 34 years later having had a good clinical result and mild persistent aortic regurgitation when assessed at 3 years. Necropsy was not performed.
Clinical signs After valve replacement, it was usual for an aortic ejection sound to be recorded at the apex and aortic and pulmonary closure (A2 and P2) were clear. In a valve considered to be clinically competent, examined at 7 months after the patient died from myocardial failure and mitral regurgitation, the cusps were totally acellular, composed of wavy collagen in regular transverse directions, and there was a single layer of endothelium covering it on the left ventricular surface. On the aortic surface, there was a coating of fibrin mesh with mononuclear lymphocytes in it. Also on this surface were crystals of refringent structures with foreign body giant cells.
These ovoid crystal like bodies have been seen in other fascial valves put in at other sites (I. Aarons, I973, personal communication). The possibility of talc from the surgeon's gloves has been raised. In 3 patients whose valves have torn acutely at the commissural attachment between 21 and 3 years later, the collagen close to the strut has broken but there is no special change in it and the rest of the valve looks as described above.
Discussion
The operative mortality is low (3 8%) and parallels that for other forms of aortic valve replacement at the National Heart Hospital. However, in assessing any new form of biological valve, concern should be with the long-term function. Though 62 per cent of patients with supported aortic fascial valves have a competent valve 3 to 4 years later, the late mortality of IO per cent, the late onset of serious aortic regurgitation in I2 per cent 2 to 4 years after operation, and the incidence of late small emboli cause grave concern.
In analysing aortic regurgitation after valve replacement, it is important to distinguish that related to technical problems occurring early, and regurgitation developing from valve failure due to a degenerative change. Eleven patients had early aortic regurgitation, severe in 5 and requiring reoperation; it was found to be caused by suture dehiscence causing peripheral leaking between the frame and the aortic wall, which is related to surgical technique and not to durability of tissue. In the other 6 patients, the source is not established, but cineaortography suggests that it is also peripheral. In the IS developing late aortic regurgitation after i8 months, it was rapidly progressive in 7 requiring reoperation, and in 6 of them the appearance was the same, namely tearing of the cusp from the commissural strut. These valves were previously competent.
It appears that the supported aortic fascial valves may fail in two ways, either by shrinking and thickening, causing progressive central regurgitation (which has only occurred once), or by sudden rupture. This is not surprising in view of the pathological findings in several valves, for the cusps are totally acellular and composed of collagen fibres in parallel wavy disposition and ruptured at the point of most stress. The progressive shrinkage in one valve seen at necropsy is difficult to understand but is similar A further problem is the occurrence of probable small emboli from the aortic valve. Six patients had visual symptoms highly suggestive of microemboli, and 3 had neurological episodes probably also embolic (Table 3) . These did not appear to be influenced by anticoagulants; 3 patients were taking anticoagulants at the time of the episode. Their nature suggested microemboli but no platelet aggregates were seen on the few valves histologically examined; however, fibrin webs have been seen on the aortic valve surface in another patient and it is possible that these are minute fibrin emboli.
In spite of these problems, there are good features. Progressive stenosis of these fascia lata valves has not yet occurred and no valve calcification has been noted radiographically. In those where gradients were found, it was related to the small size of the frame (20 mm) and none showed progressive obstruction (Table 4) . Another favourable feature is that 62 per cent of survivors were competent 3 to 4 years later. Fascia in the aortic position has functioned better than in the tricuspid or right ventricular outflow where it has been a disaster (Dalichau, and Ross, I972; Ross and Somerville, I97i) and in the mitral position there is progressive dysfunction after i8 months in many patients (Petch et al., I974) . Dalichau and his colleagues speculated that this difference was related to free movement of all 3 leaflets in the aortic position with high opening and closing pressures. In-*creasing numbers of ruptured valves are expected in the future in view of the constancy of the macroscopical appearance in those who deteriorate after 2 years.
It is of interest that the incidence of infection has been low (4%); in 2 of the patients it was probably operative making the acquired incidence only i to 2 per cent. This low incidence of endocarditis contrasts with the higher incidence reported by Senning (I967). Infection has been considered a major disadvantage of this type of valve in the past, but in our series, and that of Ionescu et al. (1972) , it has not been a problem.
In the 2 years after the first operation fascia lata appeared to provide a satisfactory valve substitute: hence the initial hopeful reports (Balcon et al., 1970; Gonzalez-Lavin and Ross, I97I; Ionescu et al., I972) . However, a closer look after a minimum 2 years' observation in every patient has demonstrated late rupture and emboli to be important problems. The fascial valve does not retain normal stress-strain characteristics which would make it superior to other forms of biological valve. Sudden rupture of cusp tissue renders fascia lata valve replacement more hazardous than fresh homograft replacement where valve rupture is uncommon. One can only be guarded about the long-term prognosis, and centres looking for a new form of aortic valve replacement should not be guided by the initial favourable reports.
